Catalyst

Slingshot members are tracking this event:

Egalet (EGLT) Plans U.S Commercial Launch of ARYMO ER C-II for Treatment of Chronic Pain in Q1 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
EGLT

100%
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords U.s Commercial Launch, Arymo Er C-ii, Chronic Pain